BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34131294)

  • 1. The sentinel node invasion level (SNIL) as a prognostic parameter in melanoma.
    Kretschmer L; Mitteldorf C; Hellriegel S; Leha A; Fichtner A; Ströbel P; Schön MP; Bremmer F
    Mod Pathol; 2021 Oct; 34(10):1839-1849. PubMed ID: 34131294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
    Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
    Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
    Baum C; Weiss C; Gebhardt C; Utikal J; Marx A; Koenen W; Géraud C
    Int J Cancer; 2017 Apr; 140(8):1907-1917. PubMed ID: 27935036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?
    Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS
    Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
    Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
    Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.
    van Lanschot CG; Koljenović S; Grunhagen DJ; Verhoef C; van Akkooi AC
    Melanoma Res; 2014 Jun; 24(3):261-6. PubMed ID: 24608184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological regression in melanoma: impact on sentinel lymph node status and survival.
    Aivazian K; Ahmed T; El Sharouni MA; Stretch JR; Saw RPM; Spillane AJ; Shannon KF; Ch'ng S; Nieweg OE; Thompson JF; Lo SN; Scolyer RA
    Mod Pathol; 2021 Nov; 34(11):1999-2008. PubMed ID: 34247192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
    Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
    Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution.
    Avilés-Izquierdo JA; Nieto-Benito LM; Lázaro-Ochaita P; Escat-Cortés JL; Marquez-Rodas I; Mercader-Cidoncha E
    Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.
    Belgrano V; Katsarelias D; Mattsson J; Olofsson Bagge R
    Eur J Surg Oncol; 2019 Feb; 45(2):225-230. PubMed ID: 30391091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.
    van der Ploeg AP; van Akkooi AC; Rutkowski P; Nowecki ZI; Michej W; Mitra A; Newton-Bishop JA; Cook M; van der Ploeg IM; Nieweg OE; van den Hout MF; van Leeuwen PA; Voit CA; Cataldo F; Testori A; Robert C; Hoekstra HJ; Verhoef C; Spatz A; Eggermont AM
    J Clin Oncol; 2011 Jun; 29(16):2206-14. PubMed ID: 21519012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
    Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
    Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
    Satzger I; Leiter U; Gräger N; Keim U; Garbe C; Gutzmer R
    Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086).
    Tropea S; Del Fiore P; Maurichi A; Patuzzo R; Santinami M; Ribero S; Quaglino P; Caliendo V; Borgognoni L; Sestini S; Giudice G; Nacchiero E; Caracò C; Cordova A; Solari N; Piazzalunga D; Tauceri F; Carcoforo P; Lombardo M; Cavallari S; Mocellin S;
    BMC Cancer; 2022 Jun; 22(1):610. PubMed ID: 35659273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma.
    Bartlett EK; Lee AY; Spanheimer PM; Bello DM; Brady MS; Ariyan CE; Coit DG
    Br J Surg; 2020 Oct; 107(11):1480-1488. PubMed ID: 32484242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
    Rios-Cantu A; Lu Y; Melendez-Elizondo V; Chen M; Gutierrez-Range A; Fadaki N; Thummala S; West-Coffee C; Cleaver J; Kashani-Sabet M; Leong SPL
    Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroscopic tumor dimension, sentinel lymph node outcome, and survival analysis among cutaneous melanoma.
    Asato MA; Moraes-Neto FA; Moraes MPT; Ocanha-Xavier JP; Alencar Marques ME; Xavier-Junior JCC
    Int J Dermatol; 2024 Jun; 63(6):765-772. PubMed ID: 38217520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.